From McMaster University, Hamilton, ON, Canada (L.A.M.); and Weill Cornell Medical College, New York (M.S.N.).
Dan L. Longo, M.D., Editor
Address reprint requests to Dr. Mandell at [email protected].
Dr. Mandell reports receiving fees for serving on a data monitoring committee from Bayer and Polyphor, fees for serving on a data and safety monitoring board from Cubist Pharmaceuticals and Shionogi, and lecture fees from Daiichi Sankyo; and Dr. Niederman, receiving consulting fees from Thermo Fisher, Paratek, Nabriva, Melinta, and Shionogi, advisory fees from Pfizer, and grant support and consulting fees from Merck and Bayer. No other potential conflict of interest relevant to this article was reported.
Disclosure forms provided by the authors are available with the full text of this article at NEJM.org.
We thank Dr. Robert P. Dickson, Division of Pulmonary and Critical Care Medicine, University of Michigan, for his assistance and thoughtful comments on an earlier version of the manuscript.
